March 17, 2017 / 11:47 AM / 3 years ago

BRIEF-Caladrius Biosciences Q4 reports loss per share of $0.73

1 Min Read

March 17 (Reuters) - Caladrius Biosciences Inc

* Caladrius Biosciences announces 2016 fourth quarter and full year financial results

* Q4 revenue rose 35 percent to $10.2 million

* Q4 loss per share $0.73

* As of December 31, 2016, Caladrius had cash and cash equivalents of $14.7 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below